Impact of Diabetes and Metformin Use on Enteropancreatic Neuroendocrine Tumors: Post Hoc Analysis of the CLARINET Study

SIMPLE SUMMARY: Lanreotide was found to be effective for preventing tumors from worsening in patients with neuroendocrine tumors of the intestines and pancreas, regardless of whether or not patients also had diabetes. Metformin, a drug for treating diabetes, also seemed to prevent tumors from worsen...

Descripción completa

Detalles Bibliográficos
Autores principales: Pusceddu, Sara, Vernieri, Claudio, Di Maio, Massimo, Prinzi, Natalie, Torchio, Martina, Corti, Francesca, Coppa, Jorgelina, Buzzoni, Roberto, Di Bartolomeo, Maria, Milione, Massimo, Regnault, Benjamin, Truong Thanh, Xuan-Mai, Mazzaferro, Vincenzo, de Braud, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750688/
https://www.ncbi.nlm.nih.gov/pubmed/35008233
http://dx.doi.org/10.3390/cancers14010069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750688/
https://www.ncbi.nlm.nih.gov/pubmed/35008233
http://dx.doi.org/10.3390/cancers14010069

Ejemplares similares